johnson & johnson - Search News

Johnson & Johnson Q4 Profit Decreases

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

Business Insider · 10h

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The

Zacks.com on MSN · 9h

Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $2 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.

FDA approves Johnson & Johnson's nasal spray for depression

Popular Science · 5h

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

U.S. News & World Report · 4h

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants,

CNN · 21h

FDA approves standalone use of J&J’s ketamine-derived depression treatment

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

Ben Johnson said 3 things every Bears fan wanted to hear

USA Today · 4h

Ben Johnson introduced as Bears head coach: 'I wanted to stay in this division'

Ben Johnson expressed gratitude for his time with the Detroit Lions head coach, calling Dan Campbell a "friend" and "mentor" as he takes over Bears

SB Nation on MSN · 3h

Ben Johnson said 3 things every Bears fan wanted to hear in his introduction

The Chicago Bears had so much optimism heading into the 2024 season. It ended the way most years do for the Bears over the last 35 years: with bitter disappointment and widespread embarrassment throughout the organization.

Reuters · 2h

Bears' Ben Johnson ready to take over 'sleeping giant'

Ben Johnson sees a winner in the Windy City, and it didn't take him long to say as much during his introductory press conference on Wednesday as the head coach of the Chicago Bears.

Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) Shareholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

5hon MSN

Johnson & Johnson clears a few hurdles, but Wall Street focuses on weak guidance

Johnson & Johnson’s stock dropped more than 3% Wednesday after the medical-technology and drug company beat estimates for the fourth quarter but as lower sales guidance for the year stoked fears of ...

MassDevice9h

Johnson & Johnson MedTech sales grow 6.2% in 2025, driven by EP, Abiomed

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond

Says starting 2025 from a position of strength. Says invested ~$50B in R&D and M&A in 2024. Says continues to invest in R&D at ...

2don MSN

What Analysts Think of Johnson & Johnson Stock Ahead of Earnings

Johnson & Johnson is set to report earnings before the bell Wednesday, with analysts expecting revenue and profit growth from ...

Johnson & Johnson Q4 Preview: Can Earnings Bring Health Care 'Back To Life'?

Johnson & Johnson is one of several Dow Jones Industrial Average stocks reporting financial results this week. A look at the ...

TipRanks on MSN3d

Johnson & Johnson’s New Acquisition Could Result in Tremendous Rewards

Staying ahead of the competition is critical in every sector, particularly in the dynamic healthcare space, where a single ...

19hon MSN

Jim Cramer on Johnson & Johnson (JNJ): ‘Make Good Money Just By Reinvesting Their Juicy Dividends’

We recently published an article titled Jim Cramer Discussed 9 Stocks for This Week’s Game Plan. In this article, we are ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Johnson & Johnson Q4 Profit Decreases

FDA approves Johnson & Johnson's nasal spray for depression

Ben Johnson said 3 things every Bears fan wanted to hear

Related topics